← Back to all signals
RESEARCH PAPER ANALYSIS

Impact of Depiction of Brown Adipose Tissue (BAT) in Baseline FDG PET/CT on Progression-free Survival in Lymphoma Patients.

AI interpretation is pending for this paper.

Open original publication →
PMID42345152
JournalAsian Pacific journal of cancer prevention : APJCP
Publication Date2026-06-01
Ingested2026-08-02 12:07 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

INTRODUCTION: Brown adipose tissue (BAT) activity seen on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has been increasingly recognized as a potential biomarker in various cancers, including lymphomas. The aim of this study was to investigate the correlation between posttreatment survival outcomes and BAT activity depicted in baseline FDG PET/CT scans in lymphoma patients. MATERIAL AND METHOD: This retrospective study was conducted at the PET/CT Section of the Department of Radiology, Aga Khan University Hospital, Karachi, Pakistan (2019-2025). The study was granted exemption by the Ethical Review Committee (2024-10630-31016). Patients with lymphoma (Hodgkin's and non-Hodgkin's; HL; NHL) whose baseline FDG PET/CT revealed BAT activation were selected. FDG PET/CT scan was acquired using a standardized protocol adopted from the European Association of Nuclear Medicine Guidelines (2015). These patients were followed for a mean of 03 years (range 15-36 months) for survival outcome (progression-free survival; PFS). RESULTS: During the study period, 259 patients with lymphomas (96 HL and 163 HL) who had baseline FDG PET/CT were selected. The cohort included 75% males (n = 194) and 25% females (n = 65), with a median age of 58 years (range: 03-80). BAT activation was identified in 27% of patients (n = 69). A significant association was observed between BAT activation and higher 3-year PFS, with activated BAT patients achieving a survival rate of 78% compared to 58% in those without activation (p < 0.05). CONCLUSION: Lymphoma patients with activated BAT depicted in their baseline FDG PET/CTs showed longer progression-free survival than those without. This study also emphasizes the need for further evaluation of BAT's role in metabolism, tumor microenvironment, and long-term prognosis in patients with lymphomas.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Effects of early menarche on adolescent health: a single-centre retrospective study. Pediatric endocrinology, diabetes, and metabolism 68.4 2 Changes in the diagnosis and management of polycystic ovary syndrome in adolescents based on recommendations of scientific societies over the last decade. Pediatric endocrinology, diabetes, and metabolism 74.8 3 Development of a Behavioral Intervention, Increasing HPV Vaccine Uptake-Delivered in Dental Settings (HPV Vaccine Uptake-DDS). Behavioral medicine (Washington, D.C.) 61.4 4 A non-inferiority randomized controlled trial comparing nebulized fentanyl and intravenous morphine for acute pain management in the emergency department. BMC emergency medicine 77.6 5 Prevalence and behavioral factors associated with penile and rectal HPV infection among men who have sex with men in Kenya. BMC infectious diseases 71.0 6 Knowledge of cervical cancer and uptake of HPV vaccine among in-school adolescent girls in Kwara State, Nigeria. Infectious agents and cancer 75.7 7 Association of coping pathways with anxiety symptoms in children with hematological cancers: a cross-sectional study using regression and fuzzy-set qualitative comparative analysis. BMC psychology 70.4 8 Clinician vs. self-assessment of mFG hirsutism scores in PCOS: can patient self-assessment serve as a reliable screening and triage tool? BMC women's health 61.5 9 Impact of Obesity on Chemotherapy Pharmacokinetics, Toxicity, and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia. Cureus 75.0 10 Head & Neck and Shoulder Desmoid-Type Fibromatosis: Presentation and Natural History of These Ultra-Rare Locations. Cancer medicine 70.7 11 Leveraging Digital Histopathology to Build Capacity and Collaboration Toward the Diagnosis of Pediatric Solid Tumors in Mexico. JCO global oncology 59.9 12 [Newborn with neurofibromatosis type 1 and meningoencephalocele]. Ugeskrift for laeger 47.5 13 Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study. Frontiers in neurology 67.0 14 Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective. Frontiers in immunology 84.27 15 Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions. Frontiers in pediatrics 82.6 16 Ewing sarcoma and paediatric cancer burden: we need more robust registries. Lancet regional health. Americas 47.5 17 Health and economic benefits of air quality improvements in France through diverse net-zero transition scenarios by 2050. Environment international 57.5 18 [Assessment of myocardial injury following anthracycline chemotherapy in children with leukemia by echocardiography]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 69.64 19 Thyroid Differentiation Score as a Molecular Bridge Between Genotype, Tumor Biology, and Radioiodine Theranostics in Thyroid Cancer. Endocrine-related cancer 64.7 20 [Development and validation of a prediction model for postoperative recurrence risk of ovarian endometriotic cysts based on preoperative imaging and clinical biomarkers]. Zhonghua yi xue za zhi 71.75 21 Lactation Management in Patients With Cancer: An Evidence-Based Framework for Surgical Practice. The American surgeon 71.0 22 Evidence-Based Recommendations for School Integration Programs Following Cancer: A Systematic Review. Journal of pediatric hematology/oncology nursing 70.0 23 Discharge Planning in Children With Cancer: Components, Strategies, and Outcomes-A Scoping Review (2021-2025). Journal of pediatric hematology/oncology nursing 58.0 24 Intervention to Support Families of Survivors of Pediatric Brain Tumor: A Scoping Review. Journal of pediatric hematology/oncology nursing 72.7 25 The role of allogeneic hematopoietic stem cell transplantation in adults with mature T-cell lymphomas. The Cochrane database of systematic reviews 88.6 26 Relative frequency of non-Wilms renal tumours in children: an institutional experience from a national tertiary referral centre in Malaysia. Pediatric surgery international 63.4 27 Childhood Cancer Risk After Assisted Reproductive Technology. JAMA 50.0 28 Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 83.39 29 The Burden of Early-Onset Gastric Cancer From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Journal of clinical gastroenterology 58.0 30 Decomposing the decline in life expectancy at birth by cause of death during the COVID-19 pandemic in Canada. Health reports 38.5 31 Integrating Surgery and Immunotherapy in the Treatment of Childhood Orbital Melanoma: A Case Report and the Literature Review. Ophthalmic plastic and reconstructive surgery 62.56 32 Co-occurrence of retinoblastoma and oculocutaneous albinism in a Mexican patient: a case report. Ophthalmic genetics 51.9
PATIENT-FRIENDLY SUMMARY

Impact of Depiction of Brown Adipose Tissue (BAT) in Baseline FDG PET/CT on Progression-free Survival in Lymphoma Patients.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic